Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-09

Clinical Trial Update: Midodrine and Albumin in Patients With Refractory Ascites [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update involving midodrine and albumin for patients with refractory ascites.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Albumin
  • Midodrine (Midodrine)

Snippet

Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh | Conditions: Refractory Ascites | Phase 3 | Status: UNKNOWN